FIL Ltd's Net Worth

$411 Million

Estimate Recalculated Feb 20, 2024 05:40PM EST

Who is FIL Ltd?

FIL Ltd has an estimated net worth of $411 Million. This is based on reported shares across multiple companies, which include IRONWOOD PHARMACEUTICALS INC, Unum Therapeutics Inc., Denali Therapeutics Inc., Surface Oncology, Inc., Xilio Therapeutics, Inc., and Structure Therapeutics Inc..

SEC CIK

FIL Ltd's CIK is 0000318989

Past Insider Trading and Trends

2017 was FIL Ltd's most active year for acquiring shares with 21 total transactions. FIL Ltd's most active month to acquire stocks was the month of November. 2012 was FIL Ltd's most active year for disposing of shares, totalling 40 transactions. FIL Ltd's most active month to dispose stocks was the month of November. 2023 saw FIL Ltd paying a total of $0.00 for 6,473,761 shares, this is the most they've acquired in one year. In 2013 FIL Ltd cashed out on 398,168 shares for a total of $2,908,530.23, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $14.915

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
-15.87%
-158.07K
$18.40
-$2,908,530.23
837.74K
Mar 28
Form 4
-19.43%
-240.10K
1M
Mar 21
Form 4
-14.69%
-212.88K
$13.25
-$2,820,594.54
1.24M
Oct 11 - Oct 15
Form 4
-1.31%
-19.30K
$13.02
-$251,278.49
1.45M
Oct 4 - Oct 8
Form 4
-0.57%
-8.40K
$13.00
-$109,232.97
1.47M
Oct 1 - Oct 3
Form 4
-6.03%
-94.69K
$13.22
-$1,251,704.32
1.48M
Sep 26 - Sep 27
Form 4
-6.52%
-235.69K
$14.46
-$3,408,714.56
3.38M
Sep 21 - Sep 25
Form 4
-8.06%
-158.33K
$13.54
-$2,143,308.69
1.81M
Sep 18 - Sep 20
Form 4
-7.26%
-153.78K
$13.14
-$2,021,119.64
1.97M
Sep 13 - Sep 17
Form 4
-1.12%
-24.10K
$13.16
-$317,119.85
2.12M
Aug 30
Form 4
-0.35%
-7.45K
$13.14
-$97,809.93
2.14M
Jul 30 - Jul 31
Form 4
-2.66%
-58.88K
$13.29
-$782,235.97
2.15M
Jul 25 - Jul 27
Form 4
-1.03%
-22.94K
$13.06
-$299,625.27
2.21M
Jul 20 - Jul 24
Form 4
-3.18%
-73.22K
$13.39
-$980,573.18
2.23M
Jul 17 - Jul 19
Form 4
-1.51%
-35.31K
$13.78
-$486,627.55
2.31M
Jul 12 - Jul 16
Form 4
-1.85%
-44.42K
$13.95
-$619,654.90
2.36M
Jul 3 - Jul 6
Form 4
-2.30%
-56.57K
$13.82
-$782,125.56
2.4M
Jun 28 - Jul 2
Form 4
-33.24%
-1.23M
2.46M
Mar 15
Form 3
0
0
No matching records found

Unum Therapeutics Inc. (COGT) Snapshot price: $5.865

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.14M
1.14M
Apr 3
Form 3/A
0
0
Form 3
0
0
No matching records found

Denali Therapeutics Inc. (DNLI) Snapshot price: $17.27

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+359.30%
3.27M
4.18M
Dec 12
Form 3
0
0
No matching records found

Surface Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
886.72K
886.72K
Apr 23
Form 3
0
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
218.71K
218.71K
Oct 26
Form 3
0
0
No matching records found